Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment
https://doi.org/10.20538/1682-0363-2009-2-118-122
Abstract
This article presents the research findings on the impact of carvedilol on the course of the necrosis myocardium focus and malone dialdegid concentration with patients, afflicted with acute myocardial infarction. The study proves that carvedilol slows down the necrosis focus formation and relieves the intensity of the no-reflow phenomenon as well as the oxydative stress, in case it is administered prior to the trombolytic therapy.
About the Authors
T. Yu. MamonovaRussian Federation
V. A. Markov
Russian Federation
V. V. Udut
Russian Federation
References
1. Бобров В.А., Симорот В.Н. Реперфузионные аритмии: механизмы развития, пути коррекции//Тер. архив. 1993. Т. 65. № 9. С. 56-62.
2. Боровиков В.П., Боровиков И.П. Статистический анализ и обработка данных в среде Windows. М.: Филинъ, 1997. 608 с.
3. Гланц С. Медико-биологическая статистика: Пер. с англ./Под ред. Н.Е. Бузикашвили, Д.В. Самойлова. М.: Практика, 1999. 459 с.
4. Пархоменко А.Н. Феномен невосстановленного кровотока у больных с острым коронарным синдромом и возможные пути улучшения тканевой перфузии//Укр. кард. журнал. 2007. № 5. Режим доступа: http://www. rql.kiev.ua/cardio_j/2007/5/parkhomenko, свободный, http://www.rql.kiev.ua/cardio_j/fr_i_all.htm, свободный.
5. Galiutano L., Lombardo A., Maseri A. et al. Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation//Heart. 2003. V. 89. P. 731-737.
6. Gressin V., Louvard Y., Pezzano M. et al. Holter recording of ventricular arrhythmias during intravenous thrombolysis for acute myocardial infarction//Am. J. Cardiology. 1992. V. 69. № 3. P. 152-159.
7. Sadanahan S., Hochman J.S. Early reperfusion, late reperfusion, and open artery hypothesis: an overview//Progress in Cardiovascular Diseases. 2000. V. 42. № 6. P. 397-404.
8. Wagner G.S., Freye C.J., Palmeri S.T. et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. I. Specificity and observer agreement//Circulation. 1982. V. 65. P. 342-347.
Review
For citations:
Mamonova T.Yu., Markov V.A., Udut V.V. Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment. Bulletin of Siberian Medicine. 2009;8(2):118-122. (In Russ.) https://doi.org/10.20538/1682-0363-2009-2-118-122